Dr. Gamze Şarbat

The molecular basis of glycogen storage disease type Ia.

Source : page de profil sur acibadem.com.tr

Glycogen storage disease type I: diagnosis and phenotype/genotype correlation.

Source : page de profil sur acibadem.com.tr

The catalytic center of glucose-6-phosphatase-HIS176 is the nucleophile forming the phosphohistidine-enzyme intermediate during catalysis.

Source : page de profil sur acibadem.com.tr

Clinical and neuropsychological outcome in 33 patients with biotinidase deficiency ascertained by nationwide newborn screening and family studies in Austria.

Source : page de profil sur acibadem.com.tr

Glucose-6-phosphatase gene mutation in Turkish patients with glycogen storage disease type Ia.

Source : page de profil sur acibadem.com.tr

Molecular genetics of type I glycogen storage disease.

Source : page de profil sur acibadem.com.tr

. Novel mutations cause biotinidase deficiency in Turkish children.

Source : page de profil sur acibadem.com.tr

Glycogen storage disease type Ia: recent experience with mutation analysis a summary of mutations reported in the literature and a newly developed diagnostic flowchart.

Source : page de profil sur acibadem.com.tr

Heterogeneous mutation in the glucose-6-phosphatase gene in Japanese patients with glycogen storage disease type Ia.

Source : page de profil sur acibadem.com.tr

Molecular aspects of glycogen storage disease type Ia in Turkish patients: a novel mutation in the glucose-6- phosphatase gene.

Source : page de profil sur acibadem.com.tr

Incidence of biotinidase deficiency in Turkish newborns.

Source : page de profil sur acibadem.com.tr

Five years experience in newborn screening for biotinidase deficiency in Istanbul.

Source : page de profil sur acibadem.com.tr